Martin Wasserman

Martin Wasserman, MD, JD, Medical Director - Immunization Practices and Scientific Affairs, GlaxoSmithKline

Martin Wasserman, M.D., Maryland Secretary of Health

Global Technology Community event features a Thursday keynote presentation by GSK Immunization Practice Medical Director Martin Wasserman.

Martin Wasserman, a GlaxoSmithKline executive who was state health secretary when Benjamin joined the department as a deputy secretary, called him "one the top leaders in public health."

Presented by: Martin P. Wasserman MD, JD, Medical Director-Immunization Practices and Scientific Affairs, GlaxoSmithKline

Only women ages 18-30 can participate in the current study, says Martin Wasserman of GlaxoSmithKline, but "we're hoping we'll eventually be able to test it in even younger women and be able to provide it to young girls," he says.

Martin Wasserman, M.D., Maryland Secretary of Health

Marty Wasserman, the chair of the ASTHO Policy Committee, thought that if STIPDA supplied ASTHO with opinions about year 2010 objectives related to injury this would create some joint, common ground between STIPDA and ASTHO.

Martin Wasserman, M.D., J.D., GlaxoSmithKline
...
Martin Wasserman, Medical Director-Immunization Practices and Scientific Affairs, GlaxoSmithKline

Session V: Special Vaccine Needs: Vaccines and Biodefense